Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Small nuclear ribonucleoprotein polypeptide B' pseudogene (also known as LOC100421673 or AC022690.1) is a human gene classified as a pseudogene, derived from the SNRPB2 gene family that normally encodes components of the spliceosomal small nuclear ribonucleoproteins (snRNPs)[1][7]. Pseudogenes are DNA sequences that resemble known genes but typically lack the ability to code for a functional protein, often due to mutations or truncations that disrupt normal gene expression. There is no evidence that this pseudogene produces a functional product or serves as a direct target for drugs or therapies. As such, it is not considered a therapeutic target, and most databases classify it only as a pseudogene with no associated biological function, disease role, or drug interaction[1][7]. Note: - If you are seeking information on the functional protein (such as the protein encoded by SNRPB or SNRPB2), refer to those gene entries specifically, as they are the relevant coding genes involved in spliceosomal function and certain autoimmune diseases[3][11]. However, LOC100421673/ENSG00000254425 is not the functional target and should not be used as such.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide B' pseudogene.